Klompas Neil A
- SEC CIK
- 0001761857
No open-market purchases or sales filed in the past year.
Current role at each company
- INM InMed Pharmaceuticals Inc.Directoras of Dec 19, 2025
- ZYME Zymeworks Inc.President & COOas of Mar 14, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Klompas Neil A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZYME Zymeworks Inc.
President & COO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 (view filing) | Mar 10 | 4 days | Klompas Neil APresident & COO | SSale | −2.98K | $7.83 | −$23.3K | −14.9%17.0K after | |
| Mar 11, 2022 (view filing) | Mar 10 | 1 day | Klompas Neil AChief Operating Officer | SSale | −2.98K | $6.88 | −$20.5K | −18.3%13.3K after |